Shockwave Medical (SWAV) Misses Q2 EPS by 7c

Shockwave Medical (NASDAQ: SWAV) reported Q2 EPS of $0.76, $0.07 worse than the analyst estimate of $0.83. Revenue for the quarter came in at $180.2 million versus the consensus estimate of $173.79 million.

For earnings history and earnings-related data on Shockwave Medical (SWAV) click here.

You May Also Be Interested In

• Hertz cuts guidance, announces notes and stock offerings, shares sink
• All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
• Darden Restaurants (DRI) PT Raised to $235 at Guggenheim